Feller struck out? from Yahoo board

Forum rules
- Comments must be civil and on topic
- Back up claims with evidence/reasoning/sources (posting links is allowed)
- No commercials/harassment/spam
Post Reply
jayfish101
Posts: 331
Joined: Tue Feb 23, 2016 5:48 pm

Feller struck out? from Yahoo board

Post by jayfish101 »

Is this the Faye Feller mystery solved?............
Her LinkedIn profile has also been updated to reflect her departure.

While she was still posting about Geron's clinical trial data from ASH 2024 as recently as December 16, 2024, her profile now lists her tenure at Geron as having ended in 2025.

Current Social Media Status

Bio Update: She has transitioned her headline from "Chief Medical Officer at Geron Corporation" to a more general description like "Oncology Drug Developer" or "Biotech Executive."

Silence on New Roles: She has not yet announced a new full-time position at another company. This is common for senior executives who may be subject to non-compete clauses or are taking a "garden leave" following a major restructuring.

The "Quiet" Exit: Unlike the CEO transition, which was heavily publicized, her social media activity simply stopped mentioning Geron after the December restructuring announcement.

Who replaced her?

As you correctly noted earlier, she is gone from the team page. The clinical oversight is now split between:

Dr. Joseph Eid: Now listed as the EVP of R&D and Chief Medical Officer.

Ahmed ElNawawi: Who was brought in as Chief Commercial Officer to handle the RYTELO launch, which was previously a shared priority for the medical team.

It seems the "confusion" was effectively the gap between her last public post in December and the company finally scrubbing the website in early 2026.
Post Reply